ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

4-Piperidinemethanol → (3-(4-((4-(Hydroxymethyl)piperidin-1-yl)methyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone

HRID 1035262
印刷

反応式

HRID 1035262 の反応式
[NH:1]1[CH2:6][CH2:5][CH:4]([CH2:7][OH:8])[CH2:3][CH2:2]1.[CH3:9][O:10][C:11]1[CH:16]=[CH:15][C:14]([C:17]2[O:21][C:20]([C:22]([N:24]3[CH2:27][CH:26]([O:28][C:29]4[CH:36]=[CH:35][C:32]([CH:33]=O)=[CH:31][CH:30]=4)[CH2:25]3)=[O:23])=[N:19][N:18]=2)=[CH:13][CH:12]=1.[Na].C([O-])(O)=O.[Na+]>ClCCl>[OH:8][CH2:7][CH:4]1[CH2:5][CH2:6][N:1]([CH2:33][C:32]2[CH:31]=[CH:30][C:29]([O:28][CH:26]3[CH2:27][N:24]([C:22]([C:20]4[O:21][C:17]([C:14]5[CH:15]=[CH:16][C:11]([O:10][CH3:9])=[CH:12][CH:13]=5)=[N:18][N:19]=4)=[O:23])[CH2:25]3)=[CH:36][CH:35]=2)[CH2:2][CH2:3]1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 4207714-PiperidinemethanolHCID 516892Sodium BicarbonateHCID 5360545SodiumHCID 580430894-(1-(5-(4-Methoxyphenyl)-1,3,4-oxadiazole-2-carbonyl)azetidin-3-yloxy)benzaldehyde

生成物 1

HCID 56599191(3-(4-((4-(Hydroxymethyl)piperidin-1-yl)methyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒2 回

実験手順

Piperidin-4-ylmethanol (0.04 g, 0.35 mmol) was dissolved in dichloromethane (2 mL) and TEA (0.052 ml, 0.38 mmol) was added. Intermediate 55A (0.11 g, 0.29 mmol) was added followed by addition of sodium triacetoxyhydroborate (0.123 g, 0.58 mmol). The mixture was stirred at RT overnight. Dichloromethane (10 mL) and NaHCO3 (sat. 2 mL) were added and the mixture was filtered through a phase separator and the solvent was removed by evaporation. The product was purified by preparative reverse-phase HPLC at pH 10 to give 81 mg (58%). 1H NMR (600 MHz, DMSO) δ 1.05-1.17 (m, 2H), 1.28-1.39 (m, 1H), 1.57-1.66 (m, 2H), 1.82-1.92 (m, 2H), 2.75-2.84 (m, 2H), 3.19-3.27 (m, 3H), 3.83-3.92 (m, 3H), 4.06-4.13 (m, 1H), 4.37-4.45 (m, 1H), 4.5-4.67 (m, 2H), 5.04-5.19 (m, 2H), 6.85 (d, 2H), 7.16-7.27 (m, 4H), 8-8.05 (m, 2H), MS (APCI+) m/z 479 [M+H]+, LC-purity: 99%.

後処理

  1. filtrationthe mixture was filtered through a phase separator
  2. customthe solvent was removed by evaporation
  3. customThe product was purified by preparative reverse-phase HPLC at pH 10
  4. customto give 81 mg (58%)

出典と根拠

ORDレコード
ord-f18a935cee03424991a0a7b73763abd2
出典データセット
uspto-grants-2013_10
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08546375B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート